![Yiftach Roth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yiftach Roth
Fondateur chez
BRAINSWAY LTD.
Fortune : 16 M $ au 31/08/2026
Profil
Dr. Yiftach Roth is a Chief Scientific Officer at Brainsway Ltd. He is on the Board of Directors at Brain Research & Development Services Ltd. and Brainsway, Inc. He received his undergraduate degree from Tel-Aviv University, a graduate degree from Tel-Aviv University and a doctorate degree from Tel-Aviv University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BRAINSWAY LTD 2,67 % | 02/06/2026 | 1 072 305 ( 2,67 % ) | 16 M $ | 31/08/2026 |
Postes actifs de Yiftach Roth
| Sociétés | Poste | Début |
|---|---|---|
| BRAINSWAY LTD. | Fondateur | 01/01/2003 |
Brain Research & Development Services Ltd. | Directeur/Membre du Conseil | - |
Brainsway, Inc.
 Brainsway, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Brainsway Ltd., Brainsway, Inc. is an Israeli medical technology company specializing in the development and manufacturing of patented deep transcranial magnetic stimulation (Deep TMS™) devices. The company is based in Jerusalem, Israel. The company’s Deep TMS technology uses a unique H-coil design to non-invasively stimulate deeper and broader brain regions than traditional TMS, targeting neural circuits involved in various psychiatric and neurological disorders. Deep TMS treatments are FDA-cleared for major depressive disorder, obsessive-compulsive disorder, and short-term smoking cessation, with additional approvals for indications such as anxiety, bipolar disorder, post-traumatic stress disorder, schizophrenia (negative symptoms), Alzheimer’s disease, autism spectrum disorder, chronic pain, multiple sclerosis, Parkinson’s disease, and post-stroke rehabilitation. Some indications are investigational or not commercially available in all markets. The company supports patients, healthcare providers, and researchers with educational resources, clinical research collaborations, practice support, and tools to locate certified treatment centers worldwide. | Directeur/Membre du Conseil | - |
Formation de Yiftach Roth
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brainsway Ltd.
 Brainsway Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and markets deep transcranial magnetic stimluation systems, novel, noninvasive medical devices | Health Technology |
Brain Research & Development Services Ltd. | Commercial Services |
Brainsway, Inc.
Brainsway, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Brainsway Ltd., Brainsway, Inc. is an Israeli medical technology company specializing in the development and manufacturing of patented deep transcranial magnetic stimulation (Deep TMS™) devices. The company is based in Jerusalem, Israel. The company’s Deep TMS technology uses a unique H-coil design to non-invasively stimulate deeper and broader brain regions than traditional TMS, targeting neural circuits involved in various psychiatric and neurological disorders. Deep TMS treatments are FDA-cleared for major depressive disorder, obsessive-compulsive disorder, and short-term smoking cessation, with additional approvals for indications such as anxiety, bipolar disorder, post-traumatic stress disorder, schizophrenia (negative symptoms), Alzheimer’s disease, autism spectrum disorder, chronic pain, multiple sclerosis, Parkinson’s disease, and post-stroke rehabilitation. Some indications are investigational or not commercially available in all markets. The company supports patients, healthcare providers, and researchers with educational resources, clinical research collaborations, practice support, and tools to locate certified treatment centers worldwide. | Electronic Technology |
